Chiba-based Biomatrix Research Develops Diagnostic Antibody Chip
This article was originally published in PharmAsia News
Executive Summary
Chiba-based Biomatrix Research has developed an antibody chip that can diagnose simple diseases. The company coats glass plates with antibodies that respond to certain proteins, and when sample fluids are applied to the antibodies, certain diseases can be detected by the kinds of antibodies that responded. Biomatrix confirmed the results by testing human blood samples. The product's commercialization is planned in 2009. The company plans to sell it to domestic and overseas research facilities after 2009. (Click here for more - Japanese language